Larson Financial Group »

Esperion Therapeutics shares owned by Larson Financial Group

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Larson Financial Group from 13F filings

Historical chart of Larson Financial Group investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Larson Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Larson Financial Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $39k 11k 3.70

More positions owned by Larson Financial Group

Spdr Series Trust State Street Spd (SPYM)
Apple (AAPL)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
American Centy Etf Tr Us Quality Grow (QGRO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Mid Cap Etf (VO)
Capital Group Global Equity SHS (CGGE)
Franklin Templeton Etf Tr Us Mid Cp Mltfct (FLQM)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Microsoft Corporation (MSFT)
Ishares Tr Msci Intl Qualty (IQLT)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Applied Materials (AMAT)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Pgim Etf Tr Active Aggregate (PAB)

View all positions for Larson Financial Group

Top funds holding Esperion Therapeutics

BlackRock
Vanguard Group
Two Seas Capital
Daniel D. Thurber
OrbiMed Advisors
State Street Corporation
Geode Capital Management
Marshall Wace
PenderFund Capital Management
AIGH Capital Management
Eversept Partners
Nuveen
Royce & Associates
Goldman Sachs Group
Two Sigma Investments

View all funds holding Esperion Therapeutics